Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates

Chemical Research in Toxicology

Volumn 29, Issue 12, 2016, Pages 1936-1955

  Lauschke, Volker M ^a   Hendriks, Delilah F G ^a   Bell, Catherine C ^a   Andersson, Tommy B ^a,b   Ingelman Sundberg, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHIP; BIOPRINTING; COCULTURE; HEP-G2 CELL LINE; HOLLOW FIBER REACTOR; HUMAN; HUMAN CELL CULTURE; LIVER CELL; LIVER FUNCTION; MICROFLUIDICS; NONHUMAN; PHENOTYPE; PRIMARY CELL CULTURE; REVIEW; SPHEROID CELL; STEM CELL; THREE DIMENSIONAL IMAGING; TOXIC HEPATITIS; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; LIVER FUNCTION TEST; METABOLISM;

ANIMALS; HEPATOCYTES; HUMANS; LIVER FUNCTION TESTS; MODELS, BIOLOGICAL;

EID: 84992503017     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/acs.chemrestox.6b00150     Document Type: Review

References (168)

1. Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D.-C., and Roudot-Thoraval, F. (2013) The burden of liver disease in Europe: A review of available epidemiological data J. Hepatol. 58, 593-608 10.1016/j.jhep.2012.12.005
2. Guidotti, L. G. and Chisari, F. V. (2006) Immunobiology and pathogenesis of viral hepatitis Annu. Rev. Pathol.: Mech. Dis. 1, 23-61 10.1146/annurev.pathol.1.110304.100230
3. Louvet, A. and Mathurin, P. (2015) Alcoholic liver disease: mechanisms of injury and targeted treatment Nat. Rev. Gastroenterol. Hepatol. 12, 231-242 10.1038/nrgastro.2015.35
4. Rinella, M. E. (2015) Nonalcoholic Fatty Liver Disease JAMA 313, 2263 10.1001/jama.2015.5370
5. Tsochatzis, E. A., Bosch, J., and Burroughs, A. K. (2014) Liver cirrhosis Lancet 383, 1749-1761 10.1016/S0140-6736(14)60121-5
6. El-Serag, H. B. (2011) Hepatocellular carcinoma N. Engl. J. Med. 365, 1118-1127 10.1056/NEJMra1001683
7. Carey, E. J., Ali, A. H., and Lindor, K. D. (2015) Primary biliary cirrhosis Lancet 386, 1565-1575 10.1016/S0140-6736(15)00154-3
8. Karlsen, T. H. and Boberg, K. M. (2013) Update on primary sclerosing cholangitis J. Hepatol. 59, 571-582 10.1016/j.jhep.2013.03.015
9. Pirmohamed, M. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients BMJ. 329, 15-19 10.1136/bmj.329.7456.15
10. Davies, E. C., Green, C. F., Taylor, S., Williamson, P. R., Mottram, D. R., and Pirmohamed, M. (2009) Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes PLoS One 4, e4439 10.1371/journal.pone.0004439
11. Lazarou, J., Pomeranz, B. H., and Corey, P. N. (1998) Incidence of Adverse Drug Reactions in Hospitalized Patients JAMA 279, 1200 10.1001/jama.279.15.1200
12. Eichelbaum, M., Ingelman-Sundberg, M., and Evans, W. E. (2006) Pharmacogenomics and Individualized Drug Therapy Annu. Rev. Med. 57, 119-137 10.1146/annurev.med.56.082103.104724
13. Ingelman-Sundberg, M. (2008) Pharmacogenomic Biomarkers for Prediction of Severe Adverse Drug Reactions N. Engl. J. Med. 358, 637-639 10.1056/NEJMe0708842
14. Fujikura, K., Ingelman-Sundberg, M., and Lauschke, V. M. (2015) Genetic variation in the human cytochrome P450 supergene family Pharmacogenet. Genomics 25, 584-594 10.1097/FPC.0000000000000172
15. Kozyra, M., Ingelman-Sundberg, M., and Lauschke, V. M. (2016) Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response Genet. Med. 10.1038/gim.2016.33
16. Sim, S. C., Kacevska, M., and Ingelman-Sundberg, M. (2013) Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects Pharmacogenomics J. 13, 1-11 10.1038/tpj.2012.45
17. Lauschke, V. M. and Ingelman-Sundberg, M. (2016) Precision Medicine and Rare Genetic Variants Trends Pharmacol. Sci. 37, 85-86 10.1016/j.tips.2015.10.006
18. Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., and Pangalos, M. N. (2014) Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework Nat. Rev. Drug Discovery 13, 419-431 10.1038/nrd4309
19. Hughes, B. (2008) Industry concern over EU hepatotoxicity guidance Nat. Rev. Drug Discovery 7, 719-719 10.1038/nrd2677
20. Tufts Center for the Study of Drug Development (2014) How the Tufts Center for the Study of Drug Development Pegged the Cost of a New Drug at $2.6 Billion, 18 Nov, 2014. http://csdd.tufts.edu/files/uploads/cost-study-backgrounder.pdf.
21. Yuan, L. and Kaplowitz, N. (2013) Mechanisms of Drug-induced Liver Injury Clin. Liver Dis. 17, 507-518 10.1016/j.cld.2013.07.002
22. Wikswo, J. P. (2014) The relevance and potential roles of microphysiological systems in biology and medicine Exp. Biol. Med. 239, 1061-1072 10.1177/1535370214542068
23. Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., Dorato, M., Van Deun, K., Smith, P., Berger, B., and Heller, A. (2000) Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals Regul. Toxicol. Pharmacol. 32, 56-67 10.1006/rtph.2000.1399
24. Project website of the Innovative Medicines Initiative project MIP-DILI (http://www.mip-dili.eu/).
25. Sison-Young, R., Lauschke, V. M., Johann, E., Alexandre, E., Antherieu, S., Aerts, H., Gerets, H. H., Labbe, G., Hoët, D., Dorau, M., Schofield, C. A., Lovatt, C. A., Holder, J. C., Stahl, S. H., Richert, L., Kitteringham, N. R., Jones, R. P., Elmasry, M., Weaver, R. J., Hewitt, P. G., Ingelman-Sundberg, M., Goldring, C. E., and Park, B. K. (2016) A multi-center assessment of the use of primary human hepatocytes, HepG2, HepaRG and Upcyte cells, with basic measures of cell health, as single cell models of acute hepatotoxicity. Arch. Toxicol., PMID 27344343.
26. Treyer, A. and Müsch, A. (2013) Hepatocyte polarity Compr. Physiol. 3, 243-287 10.1002/cphy.c120009
27. Engler, A. J., Sen, S., Sweeney, H. L., and Discher, D. E. (2006) Matrix Elasticity Directs Stem Cell Lineage Specification Cell 126, 677-689 10.1016/j.cell.2006.06.044
28. Rowe, C., Gerrard, D. T., Jenkins, R., Berry, A., Durkin, K., Sundstrom, L., Goldring, C. E., Park, B. K., Kitteringham, N. R., Hanley, K. P., and Hanley, N. A. (2013) Proteome-wide analyses of human hepatocytes during differentiation and dedifferentiation Hepatology 58, 799-809 10.1002/hep.26414
29. Heslop, J. A., Rowe, C., Walsh, J., Sison-Young, R., Jenkins, R., Kamalian, L., Kia, R., Hay, D., Jones, R. P., Malik, H. Z., Fenwick, S., Chadwick, A. E., Mills, J., Kitteringham, N. R., Goldring, C. E. P., and Park, B. K. (2016) Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile. Arch. Toxicol., DOI: 10.1007/s00204-016-1694-y
30. Pampaloni, F., Reynaud, E. G., and Stelzer, E. H. K. (2007) The third dimension bridges the gap between cell culture and live tissue Nat. Rev. Mol. Cell Biol. 8, 839-845 10.1038/nrm2236
31. Haycock, J. W., Ed. (2011) 3D Cell Culture, Vol. 695, Humana Press, Totowa, NJ.
32. Berthiaume, F., Moghe, P. V., Toner, M., and Yarmush, M. L. (1996) Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration FASEB J. 10, 1471-1484
33. Bi, Y.-a., Kazolias, D., and Duignan, D. B. (2006) Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport Drug Metab. Dispos. 34, 1658-1665 10.1124/dmd.105.009118
34. Swift, B., Pfeifer, N. D., and Brouwer, K. L. R. (2010) Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity Drug Metab. Rev. 42, 446-471 10.3109/03602530903491881
35. De Bruyn, T., Chatterjee, S., Fattah, S., Keemink, J., Nicolaï, J., Augustijns, P., and Annaert, P. (2013) Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity Expert Opin. Drug Metab. Toxicol. 9, 589-616 10.1517/17425255.2013.773973
36. Chatterjee, S., Richert, L., Augustijns, P., and Annaert, P. (2014) Hepatocyte-based in vitro model for assessment of drug-induced cholestasis Toxicol. Appl. Pharmacol. 274, 124-136 10.1016/j.taap.2013.10.032
37. Oorts, M., Baze, A., Bachellier, P., Heyd, B., Zacharias, T., Annaert, P., and Richert, L. (2016) Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes Toxicol. In Vitro 34, 179-186 10.1016/j.tiv.2016.03.008
38. Weiss, T. S., Jahn, B., Cetto, M., Jauch, K.-W., and Thasler, W. E. (2002) Collagen sandwich culture affects intracellular polyamine levels of human hepatocytes Cell Proliferation 35, 257-267 10.1046/j.1365-2184.2002.00248.x
39. Kimoto, E., Walsky, R., Zhang, H., Bi, Y. a., Whalen, K. M., Yang, Y. S., Linder, C., Xiao, Y., Iseki, K., Fenner, K. S., El-Kattan, A. F., and Lai, Y. (2012) Differential Modulation of Cytochrome P450 Activity and the Effect of 1-Aminobenzotriazole on Hepatic Transport in Sandwich-Cultured Human Hepatocytes Drug Metab. Dispos. 40, 407-411 10.1124/dmd.111.039297
40. Xu, J. J., Henstock, P. V., Dunn, M. C., Smith, A. R., Chabot, J. R., and de Graaf, D. (2008) Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury Toxicol. Sci. 105, 97-105 10.1093/toxsci/kfn109
41. Langer, R. and Tirrell, D. A. (2004) Designing materials for biology and medicine Nature 428, 487-492 10.1038/nature02388
42. Wilkening, S., Stahl, F., and Bader, A. (2003) Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties Drug Metab. Dispos. 31, 1035-1042 10.1124/dmd.31.8.1035
43. Liguori, M. J., Blomme, E. A. G., and Waring, J. F. (2008) Trovafloxacin-Induced Gene Expression Changes in Liver-Derived in Vitro Systems: Comparison of Primary Human Hepatocytes to HepG2 Cells Drug Metab. Dispos. 36, 223-233 10.1124/dmd.107.017608
44. Gerets, H. H. J., Tilmant, K., Gerin, B., Chanteux, H., Depelchin, B. O., Dhalluin, S., and Atienzar, F. A. (2012) Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins Cell Biol. Toxicol. 28, 69-87 10.1007/s10565-011-9208-4
45. Ramaiahgari, S. C., den Braver, M. W., Herpers, B., Terpstra, V., Commandeur, J. N. M., van de Water, B., and Price, L. S. (2014) A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies Arch. Toxicol. 88, 1083-1095 10.1007/s00204-014-1215-9
46. Kelm, J. M., Timmins, N. E., Brown, C. J., Fussenegger, M., and Nielsen, L. K. (2003) Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types Biotechnol. Bioeng. 83, 173-180 10.1002/bit.10655
47. Mueller, D., Koetemann, A., and Noor, F. (2011) Organotypic Cultures of Hepg2 Cells for In Vitro Toxicity Studies J. Bioeng. Biomed. Sci. 1, 1-10 10.4172/2155-9538.S2-002
48. Nakamura, K., Mizutani, R., Sanbe, A., Enosawa, S., Kasahara, M., Nakagawa, A., Ejiri, Y., Murayama, N., Miyamoto, Y., Torii, T., Kusakawa, S., Yamauchi, J., Fukuda, M., Yamazaki, H., and Tanoue, A. (2011) Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system J. Biosci. Bioeng. 111, 78-84 10.1016/j.jbiosc.2010.08.008
49. Takahashi, Y., Hori, Y., Yamamoto, T., Urashima, T., Ohara, Y., and Tanaka, H. (2015) Three-dimensional (3D) spheroid cultures improve the metabolic gene expression profiles of HepaRG cells Biosci. Rep. 1-7 10.1042/BSR20150034
50. Fey, S. J. and Wrzesinski, K. (2012) Determination of Drug Toxicity Using 3D Spheroids Constructed From an Immortal Human Hepatocyte Cell Line Toxicol. Sci. 127, 403-411 10.1093/toxsci/kfs122
51. Hart, S. N., Li, Y., Nakamoto, K., Subileau, E. A., Steen, D., and Zhong, X. B. (2010) A Comparison of Whole Genome Gene Expression Profiles of HepaRG Cells and HepG2 Cells to Primary Human Hepatocytes and Human Liver Tissues Drug Metab. Dispos. 38, 988-994 10.1124/dmd.109.031831
52. Jennen, D. G. J., Magkoufopoulou, C., Ketelslegers, H. B., van Herwijnen, M. H. M., Kleinjans, J. C. S., and van Delft, J. H. M. (2010) Comparison of HepG2 and HepaRG by Whole-Genome Gene Expression Analysis for the Purpose of Chemical Hazard Identification Toxicol. Sci. 115, 66-79 10.1093/toxsci/kfq026
53. Lübberstedt, M., Müller-Vieira, U., Mayer, M., Biemel, K. M., Knöspel, F., Knobeloch, D., Nüssler, A. K., Gerlach, J. C., and Zeilinger, K. (2011) HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro J. Pharmacol. Toxicol. Methods 63, 59-68 10.1016/j.vascn.2010.04.013
54. Sison-Young, R. L. C., Mitsa, D., Jenkins, R. E., Mottram, D., Alexandre, E., Richert, L., Aerts, H., Weaver, R. J., Jones, R. P., Johann, E., Hewitt, P. G., Ingelman-Sundberg, M., Goldring, C. E. P., Kitteringham, N. R., and Park, B. K. (2015) Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication Toxicol. Sci. 147, 412-424 10.1093/toxsci/kfv136
55. Gunness, P., Mueller, D., Shevchenko, V., Heinzle, E., Ingelman-Sundberg, M., and Noor, F. (2013) 3D Organotypic Cultures of Human HepaRG Cells: A Tool for In Vitro Toxicity Studies Toxicol. Sci. 133, 67-78 10.1093/toxsci/kft021
56. Le Vee, M., Jigorel, E., Glaise, D., Gripon, P., Guguen-Guillouzo, C., and Fardel, O. (2006) Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line Eur. J. Pharm. Sci. 28, 109-117 10.1016/j.ejps.2006.01.004
57. Leite, S. B., Wilk-Zasadna, I., Zaldivar, J. M., Airola, E., Reis-Fernandes, M. A., Mennecozzi, M., Guguen-Guillouzo, C., Chesné, C., Guillou, C., Alves, P. M., and Coecke, S. (2012) Three-Dimensional HepaRG Model As An Attractive Tool for Toxicity Testing Toxicol. Sci. 130, 106-116 10.1093/toxsci/kfs232
58. Murayama, N., Usui, T., Slawny, N., Chesne, C., and Yamazaki, H. (2015) Human HepaRG Cells can be Cultured in Hanging-drop Plates for Cytochrome P450 Induction and Function Assays Drug Metab. Lett. 9, 3-7 10.2174/1872312809666150119104806
59. Higuchi, Y., Kawai, K., Kanaki, T., Yamazaki, H., Chesne, C., Guguen-Guillouzo, C., and Suemizu, H. (2016) Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes Hepatol. Res. 46, 1045 10.1111/hepr.12644
60. Mueller, D., Krämer, L., Hoffmann, E., Klein, S., and Noor, F. (2014) 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies Toxicol. In Vitro 28, 104-112 10.1016/j.tiv.2013.06.024
61. Leite, S. B., Roosens, T., El Taghdouini, A., Mannaerts, I., Smout, A. J., Najimi, M., Sokal, E., Noor, F., Chesne, C., and van Grunsven, L. A. (2016) Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro Biomaterials 78, 1-10 10.1016/j.biomaterials.2015.11.026
62. Burkard, A., Dähn, C., Heinz, S., Zutavern, A., Sonntag-Buck, V., Maltman, D., Przyborski, S., Hewitt, N. J., and Braspenning, J. (2012) Generation of proliferating human hepatocytes using upcyte ®technology: characterisation and applications in induction and cytotoxicity assays Xenobiotica 42, 939-956 10.3109/00498254.2012.675093
63. Moody, C. A. and Laimins, L. A. (2010) Human papillomavirus oncoproteins: pathways to transformation Nat. Rev. Cancer 10, 550-560 10.1038/nrc2886
64. Levy, G., Bomze, D., Heinz, S., Ramachandran, S. D., Noerenberg, A., Cohen, M., Shibolet, O., Sklan, E., Braspenning, J., and Nahmias, Y. (2015) Long-term culture and expansion of primary human hepatocytes Nat. Biotechnol. 33, 1264-1271 10.1038/nbt.3377
65. Ramachandran, S. D., Vivares, A., Klieber, S., Hewitt, N. J., Muenst, B., Heinz, S., Walles, H., and Braspenning, J. (2015) Applicability of second-generation upcyte ®human hepatocytes for use in CYP inhibition and induction studies Pharmacol. Res. Perspect. 3, e00161 10.1002/prp2.161
66. Gómez-Lechón, M. J., Tolosa, L., Conde, I., and Donato, M. T. (2014) Competency of different cell models to predict human hepatotoxic drugs Expert Opin. Drug Metab. Toxicol. 10, 1553-1568 10.1517/17425255.2014.967680
67. Tostões, R. M., Leite, S. B., Serra, M., Jensen, J., Björquist, P., Carrondo, M. J. T., Brito, C., and Alves, P. M. (2012) Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing Hepatology 55, 1227-1236 10.1002/hep.24760
68. Messner, S., Agarkova, I., Moritz, W., and Kelm, J. M. (2013) Multi-cell type human liver microtissues for hepatotoxicity testing Arch. Toxicol. 87, 209-213 10.1007/s00204-012-0968-2
69. Bruderer, R., Bernhardt, O. M., Gandhi, T., Miladinović, S. M., Cheng, L.-Y., Messner, S., Ehrenberger, T., Zanotelli, V., Butscheid, Y., Escher, C., Vitek, O., Rinner, O., and Reiter, L. (2015) Extending the Limits of Quantitative Proteome Profiling with Data-Independent Acquisition and Application to Acetaminophen-Treated Three-Dimensional Liver Microtissues Mol. Cell. Proteomics 14, 1400-1410 10.1074/mcp.M114.044305
70. Kermanizadeh, A., L hr, M., Roursgaard, M., Messner, S., Gunness, P., Kelm, J. M., Møller, P., Stone, V., and Loft, S. (2014) Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue model Part. Fibre Toxicol. 11, 267-215 10.1186/s12989-014-0056-2
71. Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Puigvert, L. F., Dankers, A. C. A., Jacobs, F., Snoeys, J., Sison-Young, R. L., Jenkins, R. E., Nordling, Å., Mkrtchian, S., Park, B. K., Kitteringham, N. R., Goldring, C. E. P., Lauschke, V. M., and Ingelman-Sundberg, M. (2016) Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease Sci. Rep. 6, 25187 10.1038/srep25187
72. Kaplowitz, N. (2004) Drug-induced liver injury Clin. Infect. Dis. 38 (Suppl. 2) S44-48 10.1086/381446
73. Manning, F. J. and Swartz, M. (1995) Review of the Fialuridine (FIAU) Clinical Trials, National Academies Press, Washington, D.C.
74. McKenzie, R., Fried, M. W., Sallie, R., Conjeevaram, H., Di Bisceglie, A. M., Park, Y., Savarese, B., Kleiner, D., Tsokos, M., and Luciano, C. (1995) Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B N. Engl. J. Med. 333, 1099-1105 10.1056/NEJM199510263331702
75. Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., Van Natta, M., Clark, J., Brunt, E. M., Kleiner, D. E., Hoofnagle, J. H., Robuck, P. R., and CRN, N. (2010) Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N. Engl. J. Med. 362, 1675-1685 10.1056/NEJMoa0907929
76. No, D. Y., Lee, S.-A., Choi, Y. Y., Park, D., Jang, J. Y., Kim, D.-S., and Lee, S.-H. (2012) Functional 3D Human Primary Hepatocyte Spheroids Made by Co-Culturing Hepatocytes from Partial Hepatectomy Specimens and Human Adipose-Derived Stem Cells PLoS One 7, e50723-50728 10.1371/journal.pone.0050723
77. Rebelo, S. P., Costa, R., Silva, M. M., Marcelino, P., Brito, C., and Alves, P. M. (2015) Three-dimensional co-culture of human hepatocytes and mesenchymal stem cells: improved functionality in long-term bioreactor cultures. J. Tissue Eng. Regener. Med., DOI: 10.1002/term.2099.
78. Palakkan, A. A., Hay, D. C., PR, A. K., Tv, K., and Ross, J. A. (2013) Liver tissue engineering and cell sources: issues and challenges Liver Int. 33, 666-676 10.1111/liv.12134
79. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007) Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors Cell 131, 861-872 10.1016/j.cell.2007.11.019
80. Daley, G. Q., Ahrlund-Richter, L., Auerbach, J. M., Benvenisty, N., Charo, R. A., Chen, G., Deng, H.-K., Goldstein, L. S., Hudson, K. L., Hyun, I., Junn, S. C., Love, J., Lee, E. H., McLaren, A., Mummery, C. L., Nakatsuji, N., Racowsky, C., Rooke, H., Rossant, J., Schöler, H. R., Solbakk, J. H., Taylor, P., Trounson, A. O., Weissman, I. L., Wilmut, I., Yu, J., and Zoloth, L. (2007) The ISSCR guidelines for human embryonic stem cell research Science 315, 603-604 10.1126/science.1139337
81. Kahler, D. J., Ahmad, F. S., Ritz, A., Hua, H., Moroziewicz, D. N., Sproul, A. A., Dusenberry, C. R., Shang, L., Paull, D., Zimmer, M., Weiss, K. A., Egli, D., and Noggle, S. A. (2013) Improved Methods for Reprogramming Human Dermal Fibroblasts Using Fluorescence Activated Cell Sorting PLoS One 8, e59867-59812 10.1371/journal.pone.0059867
82. Rashid, S. T., Corbineau, S., Hannan, N., Marciniak, S. J., Miranda, E., Alexander, G., Huang-Doran, I., Griffin, J., Ahrlund-Richter, L., Skepper, J., Semple, R., Weber, A., Lomas, D. A., and Vallier, L. (2010) Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells J. Clin. Invest. 120, 3127-3136 10.1172/JCI43122
83. Carpentier, A., Tesfaye, A., Chu, V., Nimgaonkar, I., Zhang, F., Lee, S. B., Thorgeirsson, S. S., Feinstone, S. M., and Liang, T. J. (2014) Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model J. Clin. Invest. 124, 4953-4964 10.1172/JCI75456
84. Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. R., Yabuuchi, A., Takeuchi, A., Cunniff, K. C., Hongguang, H., Mckinney-Freeman, S., Naveiras, O., Yoon, T. J., Irizarry, R. A., Jung, N., Seita, J., Hanna, J., Murakami, P., Jaenisch, R., Weissleder, R., Orkin, S. H., Weissman, I. L., Feinberg, A. P., and Daley, G. Q. (2010) Epigenetic memory in induced pluripotent stem cells Nature 467, 285-290 10.1038/nature09342
85. Bar-Nur, O., Russ, H. A., Efrat, S., and Benvenisty, N. (2011) Epigenetic Memory and Preferential Lineage-Specific Differentiation in Induced Pluripotent Stem Cells Derived from Human Pancreatic Islet Beta Cells Cell Stem Cell 9, 17-23 10.1016/j.stem.2011.06.007
86. Polo, J. M., Liu, S., Figueroa, M. E., Kulalert, W., Eminli, S., Tan, K. Y., Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T., Natesan, S., Wagers, A. J., Melnick, A., Evans, T., and Hochedlinger, K. (2010) Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells Nat. Biotechnol. 28, 848-855 10.1038/nbt.1667
87. Chin, M. H., Mason, M. J., Xie, W., Volinia, S., Singer, M., Peterson, C., Ambartsumyan, G., Aimiuwu, O., Richter, L., Zhang, J., Khvorostov, I., Ott, V., Grunstein, M., Lavon, N., Benvenisty, N., Croce, C. M., Clark, A. T., Baxter, T., Pyle, A. D., Teitell, M. A., Pelegrini, M., Plath, K., and Lowry, W. E. (2009) Induced Pluripotent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression Signatures Cell Stem Cell 5, 111-123 10.1016/j.stem.2009.06.008
88. Boland, M. J., Hazen, J. L., Nazor, K. L., Rodriguez, A. R., Gifford, W., Martin, G., Kupriyanov, S., and Baldwin, K. K. (2009) Adult mice generated from induced pluripotent stem cells Nature 461, 91-94 10.1038/nature08310
89. Narsinh, K. H., Sun, N., Sanchez-Freire, V., Lee, A. S., Almeida, P., Hu, S., Jan, T., Wilson, K. D., Leong, D., Rosenberg, J., Yao, M., Robbins, R. C., and Wu, J. C. (2011) Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells J. Clin. Invest. 121, 1217-1221 10.1172/JCI44635
90. Hu, B. Y., Weick, J. P., Yu, J., Ma, L. X., Zhang, X. Q., Thomson, J. A., and Zhang, S. C. (2010) Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency Proc. Natl. Acad. Sci. U. S. A. 107, 4335-4340 10.1073/pnas.0910012107
91. Feng, Q., Lu, S.-J., Klimanskaya, I., Gomes, I., Kim, D., Chung, Y., Honig, G. R., Kim, K.-S., and Lanza, R. (2010) Hemangioblastic Derivatives from Human Induced Pluripotent Stem Cells Exhibit Limited Expansion and Early Senescence Stem Cells 28, 704-712 10.1002/stem.321
92. Salomonis, N., Dexheimer, P. J., Omberg, L., Schroll, R., Bush, S., Huo, J., Schriml, L., Sui, S. H., Keddache, M., Mayhew, C., Shanmukhappa, S. K., Wells, J., Daily, K., Hubler, S., Wang, Y., Zambidis, E., Margolin, A., Hide, W., Hatzopoulos, A. K., Malik, P., Cancelas, J. A., Aronow, B. J., and Lutzko, C. (2016) Integrated Genomic Analysis of Diverse Induced Pluripotent Stem Cells from the Progenitor Cell Biology Consortium Stem Cell Rep. 7, 110-125 10.1016/j.stemcr.2016.05.006
93. Song, Z., Cai, J., Liu, Y., Zhao, D., Yong, J., Duo, S., Song, X., Guo, Y., Zhao, Y., Qin, H., Yin, X., Wu, C., Che, J., Lu, S., Ding, M., and Deng, H. (2009) Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells Cell Res. 19, 1233-1242 10.1038/cr.2009.107
94. Si-Tayeb, K., Noto, F. K., Nagaoka, M., Li, J., Battle, M. A., Duris, C., North, P. E., Dalton, S., and Duncan, S. A. (2010) Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells Hepatology 51, 297-305 10.1002/hep.23354
95. Touboul, T., Hannan, N. R. F., Corbineau, S., Martinez, A., Martinet, C., Branchereau, S., Mainot, S., Strick-Marchand, H., Pedersen, R., Di Santo, J., Weber, A., and Vallier, L. (2010) Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development Hepatology 51, 1754-1765 10.1002/hep.23506
96. Zhao, D., Chen, S., Duo, S., Xiang, C., Jia, J., Guo, M., Lai, W., Lu, S., and Deng, H. (2013) Promotion of the efficient metabolic maturation of human pluripotent stem cell-derived hepatocytes by correcting specification defects Cell Res. 23, 157-161 10.1038/cr.2012.144
97. Schwartz, R. E., Fleming, H. E., Khetani, S. R., and Bhatia, S. N. (2014) Pluripotent stem cell-derived hepatocyte-like cells Biotechnol. Adv. 32, 504-513 10.1016/j.biotechadv.2014.01.003
98. Baxter, M., Withey, S., Harrison, S., Segeritz, C.-P., Zhang, F., Atkinson-Dell, R., Rowe, C., Gerrard, D. T., Sison-Young, R., Jenkins, R., Henry, J., Berry, A. A., Mohamet, L., Best, M., Fenwick, S. W., Malik, H., Kitteringham, N. R., Goldring, C. E., Piper Hanley, K., Vallier, L., and Hanley, N. A. (2015) Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes J. Hepatol. 62, 581-589 10.1016/j.jhep.2014.10.016
99. Gieseck, R. L., III, Hannan, N. R. F., Bort, R., Hanley, N. A., Drake, R. A. L., Cameron, G. W. W., Wynn, T. A., and Vallier, L. (2014) Maturation of Induced Pluripotent Stem Cell Derived Hepatocytes by 3D-Culture PLoS One 9, e86372 10.1371/journal.pone.0086372
100. Kim, J. H., Jang, Y. J., An, S. Y., Son, J., Lee, J., Lee, G., Park, J. Y., Park, H.-J., Hwang, D.-Y., Kim, J.-H., and Han, J. (2015) Enhanced Metabolizing Activity of Human ES Cell-Derived Hepatocytes Using a 3D Culture System with Repeated Exposures to Xenobiotics Toxicol. Sci. 147, 190-206 10.1093/toxsci/kfv121
101. Giobbe, G. G., Michielin, F., Luni, C., Giulitti, S., Martewicz, S., Dupont, S., Floreani, A., and Elvassore, N. (2015) Functional differentiation of human pluripotent stem cells on a chip Nat. Methods 12, 637-640 10.1038/nmeth.3411
102. Sivertsson, L., Synnergren, J., Jensen, J., Björquist, P., and Ingelman-Sundberg, M. (2013) Hepatic Differentiation and Maturation of Human Embryonic Stem Cells Cultured in a Perfused Three-Dimensional Bioreactor Stem Cells Dev. 22, 581-594 10.1089/scd.2012.0202
103. Berger, D. R., Ware, B. R., Davidson, M. D., Allsup, S. R., and Khetani, S. R. (2015) Enhancing the functional maturity of induced pluripotent stem cell-derived human hepatocytes by controlled presentation of cell-cell interactions in vitro Hepatology 61, 1370-1381 10.1002/hep.27621
104. Ogawa, S., Surapisitchat, J., Virtanen, C., Ogawa, M., Niapour, M., Sugamori, K. S., Wang, S., Tamblyn, L., Guillemette, C., Hoffmann, E., Zhao, B., Strom, S., Laposa, R. R., Tyndale, R. F., Grant, D. M., and Keller, G. (2013) Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes Development 140, 3285-3296 10.1242/dev.090266
105. Dankel, S. N., Hoang, T., Flågeng, M. H., Sagen, J. V., and Mellgren, G. (2010) cAMP-mediated regulation of HNF-4alpha depends on the level of coactivator PGC-1alpha Biochim. Biophys. Acta, Mol. Cell Res. 1803, 1013-1019 10.1016/j.bbamcr.2010.05.008
106. Subramanian, K., Owens, D. J., Raju, R., Firpo, M., O'Brien, T. D., Verfaillie, C. M., and Hu, W.-S. (2014) Spheroid Culture for Enhanced Differentiation of Human Embryonic Stem Cells to Hepatocyte-Like Cells Stem Cells Dev. 23, 124-131 10.1089/scd.2013.0097
107. Sengupta, S., Johnson, B. P., Swanson, S. A., Stewart, R., Bradfield, C. A., and Thomson, J. A. (2014) Aggregate Culture of Human Embryonic Stem Cell-Derived Hepatocytes in Suspension Are an Improved In Vitro Model for Drug Metabolism and Toxicity Testing Toxicol. Sci. 140, 236-245 10.1093/toxsci/kfu069
108. Bales, J. R., Sadler, P. J., Nicholson, J. K., and Timbrell, J. A. (1984) Urinary excretion of acetaminophen and its metabolites as studied by proton NMR spectroscopy Clin. Chem. 30, 1631-1636
109. Mutlib, A. E., Goosen, T. C., Bauman, J. N., Williams, J. A., Kulkarni, S., and Kostrubsky, S. (2006) Kinetics of Acetaminophen Glucuronidation by UDP-Glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential Implications in Acetaminophen-Induced Hepatotoxicity Chem. Res. Toxicol. 19, 701-709 10.1021/tx050317i
110. Takayama, K., Kawabata, K., Nagamoto, Y., Kishimoto, K., Tashiro, K., Sakurai, F., Tachibana, M., Kanda, K., Hayakawa, T., Furue, M. K., and Mizuguchi, H. (2013) 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing Biomaterials 34, 1781-1789 10.1016/j.biomaterials.2012.11.029
111. Du, Y., Wang, J., Jia, J., Song, N., Xiang, C., Xu, J., Hou, Z., Su, X., Liu, B., Jiang, T., Zhao, D., Sun, Y., Shu, J., Guo, Q., Yin, M., Sun, D., Lu, S., Shi, Y., and Deng, H. (2014) Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming Cell Stem Cell 14, 394-403 10.1016/j.stem.2014.01.008
112. Kim, S.-E., An, S. Y., Woo, D.-H., Han, J., Kim, J. H., Jang, Y. J., Son, J. S., Yang, H., Cheon, Y. P., and Kim, J.-H. (2013) Engraftment Potential of Spheroid-Forming Hepatic Endoderm Derived from Human Embryonic Stem Cells Stem Cells Dev. 22, 1818-1829 10.1089/scd.2012.0401
113. Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., Aoyama, S., Adachi, Y., and Taniguchi, H. (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant Nature 499, 481-484 10.1038/nature12271
114. Dash, A., Simmers, M. B., Deering, T. G., Berry, D. J., Feaver, R. E., Hastings, N. E., Pruett, T. L., LeCluyse, E. L., Blackman, B. R., and Wamhoff, B. R. (2013) Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro Am. J. Physiol. Cell Physiol. 304, C1053-1063 10.1152/ajpcell.00331.2012
115. Rashidi, H., Alhaque, S., Szkolnicka, D., Flint, O., and Hay, D. C. (2016) Fluid shear stress modulation of hepatocyte-like cell function Arch. Toxicol. 90, 1757-1761 10.1007/s00204-016-1689-8
116. Gerlach, J. r. C., Mutig, K., Sauer, I. M., Schrade, P., Efimova, E., Mieder, T., Naumann, G. t., Grunwald, A., Pless, G., Mas, A., Bachmann, S., Neuhaus, P., and Zeilinger, K. (2003) Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study Transplantation 76, 781-786 10.1097/01.TP.0000083319.36931.32
117. Zeilinger, K., Schreiter, T., Darnell, M., Söderdahl, T., Lübberstedt, M., Dillner, B., Knobeloch, D., Nüssler, A. K., Gerlach, J. C., and Andersson, T. B. (2011) Scaling Down of a Clinical Three-Dimensional Perfusion Multicompartment Hollow Fiber Liver Bioreactor Developed for Extracorporeal Liver Support to an Analytical Scale Device Useful for Hepatic Pharmacological In VitroStudies Tissue Eng., Part C 17, 549-556 10.1089/ten.tec.2010.0580
118. Hoffmann, S. A., Müller-Vieira, U., Biemel, K., Knobeloch, D., Heydel, S., Lübberstedt, M., Nüssler, A. K., Andersson, T. B., Gerlach, J. C., and Zeilinger, K. (2012) Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studies Biotechnol. Bioeng. 109, 3172-3181 10.1002/bit.24573
119. Ulvestad, M., Darnell, M., Molden, E., Ellis, E., Åsberg, A., and Andersson, T. B. (2012) Evaluation of organic anion-transporting polypeptide 1B1 and CYP3A4 activities in primary human hepatocytes and HepaRG cells cultured in a dynamic three-dimensional bioreactor system J. Pharmacol. Exp. Ther. 343, 145-156 10.1124/jpet.112.195750
120. Darnell, M., Ulvestad, M., Ellis, E., Weidolf, L., and Andersson, T. B. (2012) In Vitro Evaluation of Major In Vivo Drug Metabolic Pathways Using Primary Human Hepatocytes and HepaRG Cells in Suspension and a Dynamic Three-Dimensional Bioreactor System J. Pharmacol. Exp. Ther. 343, 134-144 10.1124/jpet.112.195834
121. Khetani, S. R. and Bhatia, S. N. (2007) Microscale culture of human liver cells for drug development Nat. Biotechnol. 26, 120-126 10.1038/nbt1361
122. Khetani, S. R., Kanchagar, C., Ukairo, O., Krzyzewski, S., Moore, A., Shi, J., Aoyama, S., Aleo, M., and Will, Y. (2013) Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans Toxicol. Sci. 132, 107-117 10.1093/toxsci/kfs326
123. Persson, M., Løye, A. F., Jacquet, M., Mow, N. S., Thougaard, A. V., Mow, T., and Hornberg, J. J. (2014) High-content analysis/screening for predictive toxicology: application to hepatotoxicity and genotoxicity Basic Clin. Pharmacol. Toxicol. 115, 18-23 10.1111/bcpt.12200
124. Garside, H., Marcoe, K. F., Chesnut-Speelman, J., Foster, A. J., Muthas, D., Kenna, J. G., Warrior, U., Bowes, J., and Baumgartner, J. (2014) Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes Toxicol. In Vitro 28, 171-181 10.1016/j.tiv.2013.10.015
125. Ballard, T. E., Wang, S., Cox, L. M., Moen, M. A., Krzyzewski, S., Ukairo, O., and Obach, R. S. (2016) Application of a Micropatterned Cocultured Hepatocyte System To Predict Preclinical and Human-Specific Drug Metabolism Drug Metab. Dispos. 44, 172-179 10.1124/dmd.115.066688
126. Chan, T. S., Yu, H., Moore, A., Khetani, S. R., and Tweedie, D. (2013) Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac Drug Metab. Dispos. 41, 2024-2032 10.1124/dmd.113.053397
127. Wang, W. W., Khetani, S. R., Krzyzewski, S., Duignan, D. B., and Obach, R. S. (2010) Assessment of a Micropatterned Hepatocyte Coculture System to Generate Major Human Excretory and Circulating Drug Metabolites Drug Metab. Dispos. 38, 1900-1905 10.1124/dmd.110.034876
128. Ware, B. R., Berger, D. R., and Khetani, S. R. (2015) Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes Toxicol. Sci. 145, 252-262 10.1093/toxsci/kfv048
129. Nguyen, T. V., Ukairo, O., Khetani, S. R., McVay, M., Kanchagar, C., Seghezzi, W., Ayanoglu, G., Irrechukwu, O., and Evers, R. (2015) Establishment of a Hepatocyte-Kupffer Cell Coculture Model for Assessment of Proinflammatory Cytokine Effects on Metabolizing Enzymes and Drug Transporters Drug Metab. Dispos. 43, 774-785 10.1124/dmd.114.061317
130. Khetani, S. R., Szulgit, G., Del Rio, J. A., Barlow, C., and Bhatia, S. N. (2004) Exploring interactions between rat hepatocytes and nonparenchymal cells using gene expression profiling Hepatology 40, 545-554 10.1002/hep.20351
131. Khetani, S. R., Chen, A. A., Ranscht, B., and Bhatia, S. N. (2008) T-cadherin modulates hepatocyte functions in vitro FASEB J. 22, 3768-3775 10.1096/fj.07-105155
132. Meng, Q. (2010) Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity Expert Opin. Drug Metab. Toxicol. 6, 733-746 10.1517/17425251003674356
133. Domansky, K., Inman, W., Serdy, J., Dash, A., Lim, M. H. M., and Griffith, L. G. (2010) Perfused multiwell plate for 3D liver tissue engineering Lab Chip 10, 51-58 10.1039/B913221J
134. Vivares, A., Salle-Lefort, S., Arabeyre-Fabre, C., Ngo, R., Penarier, G., Bremond, M., Moliner, P., Gallas, J.-F., Fabre, G., and Klieber, S. (2015) Morphological behaviour and metabolic capacity of cryopreserved human primary hepatocytes cultivated in a perfused multiwell device Xenobiotica 45, 29-44 10.3109/00498254.2014.944612
135. Sarkar, U., Rivera-Burgos, D., Large, E. M., Hughes, D. J., Ravindra, K. C., Dyer, R. L., Ebrahimkhani, M. R., Wishnok, J. S., Griffith, L. G., and Tannenbaum, S. R. (2015) Metabolite Profiling and Pharmacokinetic Evaluation of Hydrocortisone in a Perfused Three-Dimensional Human Liver Bioreactor Drug Metab. Dispos. 43, 1091-1099 10.1124/dmd.115.063495
136. Legendre, A., Jacques, S., Dumont, F., Cotton, J., Paullier, P., Fleury, M. J., and Leclerc, E. (2014) Investigation of the hepatotoxicity of flutamide: Pro-survival/apoptotic and necrotic switch in primary rat hepatocytes characterized by metabolic and transcriptomic profiles in microfluidic liver biochips Toxicol. In Vitro 28, 1075-1087 10.1016/j.tiv.2014.04.008
137. Toh, Y.-C., Lim, T. C., Tai, D., Xiao, G., van Noort, D., and Yu, H. (2009) A microfluidic 3D hepatocyte chip for drug toxicity testing Lab Chip 9, 2026-2010 10.1039/b900912d
138. James, L. P., Letzig, L., Simpson, P. M., Capparelli, E., Roberts, D. W., Hinson, J. A., Davern, T. J., and Lee, W. M. (2009) Pharmacokinetics of Acetaminophen-Protein Adducts in Adults with Acetaminophen Overdose and Acute Liver Failure Drug Metab. Dispos. 37, 1779-1784 10.1124/dmd.108.026195
139. Bavli, D., Prill, S., Ezra, E., Levy, G., Cohen, M., Vinken, M., Vanfleteren, J., Jaeger, M., and Nahmias, Y. (2016) Real-time monitoring of metabolic function in liver-on-chip microdevices tracks the dynamics of mitochondrial dysfunction Proc. Natl. Acad. Sci. U. S. A. 113, E2231-E2240 10.1073/pnas.1522556113
140. Rennert, K., Steinborn, S., Gröger, M., Ungerböck, B., Jank, A.-M., Ehgartner, J., Nietzsche, S., Dinger, J., Kiehntopf, M., Funke, H., Peters, F. T., Lupp, A., Gärtner, C., Mayr, T., Bauer, M., Huber, O., and Mosig, A. S. (2015) A microfluidically perfused three dimensional human liver model Biomaterials 71, 119-131 10.1016/j.biomaterials.2015.08.043
141. van Midwoud, P. M., Merema, M. T., Verpoorte, E., and Groothuis, G. M. M. (2010) A microfluidic approach for in vitro assessment of interorgan interactions in drug metabolism using intestinal and liver slices Lab Chip 10, 2778-2779 10.1039/c0lc00043d
142. Chiang, J. Y. L. (2009) Bile acids: regulation of synthesis J. Lipid Res. 50, 1955-1966 10.1194/jlr.R900010-JLR200
143. Wagner, I., Materne, E.-M., Brincker, S., Süßbier, U., Frädrich, C., Busek, M., Sonntag, F., Sakharov, D. A., Trushkin, E. V., Tonevitsky, A. G., Lauster, R., and Marx, U. (2013) A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture Lab Chip 13, 3538-3511 10.1039/c3lc50234a
144. Maschmeyer, I., Lorenz, A. K., Schimek, K., Hasenberg, T., Ramme, A. P., Hübner, J., Lindner, M., Drewell, C., Bauer, S., Thomas, A., Sambo, N. S., Sonntag, F., Lauster, R., and Marx, U. (2015) A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents Lab Chip 15, 2688-2699 10.1039/C5LC00392J
145. Oleaga, C., Bernabini, C., Smith, A. S. T., Srinivasan, B., Jackson, M., McLamb, W., Platt, V., Bridges, R., Cai, Y., Santhanam, N., Berry, B., Najjar, S., Akanda, N., Guo, X., Martin, C., Ekman, G., Esch, M. B., Langer, J., Ouedraogo, G., Cotovio, J., Breton, L., Shuler, M. L., and Hickman, J. J. (2016) Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs Sci. Rep. 6, 20030 10.1038/srep20030
146. Miller, P. G. and Shuler, M. L. (2016) Design and demonstration of a pumpless 14 compartment microphysiological system Biotechnol. Bioeng. 113, 2213-2227 10.1002/bit.25989
147. Choucha-Snouber, L., Aninat, C., Grsicom, L., Madalinski, G., Brochot, C., Poleni, P. E., Razan, F., Guillouzo, C. G., Legallais, C., Corlu, A., and Leclerc, E. (2013) Investigation of ifosfamide nephrotoxicity induced in a liver-kidney co-culture biochip Biotechnol. Bioeng. 110, 597-608 10.1002/bit.24707
148. Sung, J. H. and Shuler, M. L. (2009) A micro cell culture analog (μCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs Lab Chip 9, 1385-1310 10.1039/b901377f
149. Ma, L., Barker, J., Zhou, C., Li, W., Zhang, J., Lin, B., Foltz, G., Küblbeck, J., and Honkakoski, P. (2012) Towards personalized medicine with a three-dimensional micro-scale perfusion-based two-chamber tissue model system Biomaterials 33, 4353-4361 10.1016/j.biomaterials.2012.02.054
150. Imura, Y., Sato, K., and Yoshimura, E. (2010) Micro Total Bioassay System for Ingested Substances: Assessment of Intestinal Absorption, Hepatic Metabolism, and Bioactivity Anal. Chem. 82, 9983-9988 10.1021/ac100806x
151. Imura, Y., Yoshimura, E., and Sato, K. (2012) Micro total bioassay system for oral drugs: evaluation of gastrointestinal degradation, intestinal absorption, hepatic metabolism, and bioactivity Anal. Sci. 28, 197-199 10.2116/analsci.28.197
152. Zhu, W., Ma, X., Gou, M., Mei, D., Zhang, K., and Chen, S. (2016) 3D printing of functional biomaterials for tissue engineering Curr. Opin. Biotechnol. 40, 103-112 10.1016/j.copbio.2016.03.014
153. Ma, X., Qu, X., Zhu, W., Li, Y.-S., Yuan, S., Zhang, H., Liu, J., Wang, P., Lai, C. S. E., Zanella, F., Feng, G.-S., Sheikh, F., Chien, S., and Chen, S. (2016) Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting Proc. Natl. Acad. Sci. U. S. A. 113, 2206-2211 10.1073/pnas.1524510113
154. Norotte, C., Marga, F. S., Niklason, L. E., and Forgacs, G. (2009) Scaffold-free vascular tissue engineering using bioprinting Biomaterials 30, 5910-5917 10.1016/j.biomaterials.2009.06.034
155. Nguyen, D. G., Funk, J., Robbins, J. B., Crogan-Grundy, C., Presnell, S. C., Singer, T., and Roth, A. B. (2016) Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro PLoS One 11, e0158674-17 10.1371/journal.pone.0158674
156. Hartung, T. and Wendel, A. (1991) Endotoxin-inducible cytotoxicity in liver cell cultures - I Biochem. Pharmacol. 42, 1129-1135 10.1016/0006-2952(91)90298-J
157. Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., Braeuning, A., Budinsky, R. A., Burkhardt, B., Cameron, N. R., Camussi, G., Cho, C.-S., Choi, Y.-J., Craig Rowlands, J., Dahmen, U., Damm, G., Dirsch, O., Donato, M. T., Dong, J., Dooley, S., Drasdo, D., Eakins, R., Ferreira, K. S., Fonsato, V., Fraczek, J., Gebhardt, R., Gibson, A., Glanemann, M., Goldring, C. E. P., Gómez Lechón, M. J., Groothuis, G. M. M., Gustavsson, L., Guyot, C., Hallifax, D., Hammad, S., Hayward, A., Hellerbrand, C., Hewitt, P., Hoehme, S., Holzhütter, H.-G., Houston, J. B., Hrach, J., Ito, K., Jaeschke, H., Keitel, V., Kelm, J. M., Kevin Park, B., Kordes, C., Kullak-Ublick, G. A., LeCluyse, E. L., Lu, P., Luebke-Wheeler, J., Lutz, A., Maltman, D. J., Matz-Soja, M., McMullen, P., Merfort, I., Messner, S., Meyer, C., Mwinyi, J., Naisbitt, D. J., Nüssler, A. K., Olinga, P., Pampaloni, F., Pi, J., Pluta, L., Przyborski, S. A., Ramachandran, A., Rogiers, V., Rowe, C., Schelcher, C., Schmich, K., Schwarz, M., Singh, B., Stelzer, E. H. K., Stieger, B., Stöber, R., Sugiyama, Y., Tetta, C., Thasler, W. E., Vanhaecke, T., Vinken, M., Weiss, T. S., Widera, A., Woods, C. G., Xu, J. J., Yarborough, K. M., and Hengstler, J. G. (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME Arch. Toxicol. 87, 1315-1530 10.1007/s00204-013-1078-5
158. Daly, A. K., Donaldson, P. T., Bhatnagar, P., Shen, Y., Peaposer, I., Floratos, A., Daly, M. J., Goldstein, D. B., John, S., Nelson, M. R., Graham, J., Park, B. K., Dillon, J. F., Bernal, W., Cordell, H. J., Pirmohamed, M., Aithal, G. P., and Day, C. P. (2009) HLA-B5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin Nat. Genet. 41, 816-819 10.1038/ng.379
159. Spraggs, C. F., Budde, L. R., Briley, L. P., Bing, N., Cox, C. J., King, K. S., Whittaker, J. C., Mooser, V. E., Preston, A. J., Stein, S. H., and Cardon, L. R. (2011) HLA-DQA102:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer J. Clin. Oncol. 29, 667-673 10.1200/JCO.2010.31.3197
160. Singer, J. B., Lewitzky, S., Leroy, E., Yang, F., Zhao, X., Klickstein, L., Wright, T. M., Meyer, J., and Paulding, C. A. (2010) A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury Nat. Genet. 42, 711-714 10.1038/ng.632
161. Kindmark, A., Jawaid, A., Harbron, C. G., Barratt, B. J., Bengtsson, O. F., Andersson, T. B., Carlsson, S., Cederbrant, K. E., Gibson, N. J., Armstrong, M., Lagerström-Fermér, M. E., Dellsén, A., Brown, E. M., Thornton, M., Dukes, C., Jenkins, S. C., Firth, M. A., Harrod, G. O., Pinel, T. H., Billing-Clason, S. M. E., Cardon, L. R., and March, R. E. (2008) Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis Pharmacogenomics J. 8, 186-195 10.1038/sj.tpj.6500458
162. Monshi, M. M., Faulkner, L., Gibson, A., Jenkins, R. E., Farrell, J., Earnshaw, C. J., Alfirevic, A., Cederbrant, K., Daly, A. K., French, N., Pirmohamed, M., Park, B. K., and Naisbitt, D. J. (2013) Human leukocyte antigen (HLA)-B57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury Hepatology 57, 727-739 10.1002/hep.26077
163. Wuillemin, N., Terracciano, L., Beltraminelli, H., Schlapbach, C., Fontana, S., Krähenbühl, S., Pichler, W. J., and Yerly, D. (2014) T Cells Infiltrate the Liver and Kill Hepatocytes in HLA-B57:01-Associated Floxacillin-Induced Liver Injury Am. J. Pathol. 184, 1677-1682 10.1016/j.ajpath.2014.02.018
164. LeCluyse, E. L., Witek, R. P., Andersen, M. E., and Powers, M. J. (2012) Organotypic liver culture models: Meeting current challenges in toxicity testing Crit. Rev. Toxicol. 42, 501-548 10.3109/10408444.2012.682115
165. Roth, A. and Singer, T. (2014) The application of 3D cell models to support drug safety assessment: Opportunities & challenges Adv. Drug Delivery Rev. 69-70, 179-189 10.1016/j.addr.2013.12.005
166. OECD guidelines for the in vitro testing of chemicals for skin corrosion (http://www.oecd-ilibrary.org/environment/test-no-431-in-vitro-skin-corrosion-human-skin-model-test-9789264071148-en).
167. OECD guidelines for the in vitro testing of chemicals for skin irritation (http://www.oecd.org/env/test-no-439-in-vitro-skin-irritation-reconstructed-human-epidermis-test-method-9789264242845-en.htm).
168. The internet pathology laboratory for medical education (http://library.med.utah.edu/WebPath/LIVEHTML/LIVERIDX.html).